Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changlin Mei

Showing results (161-170 of 181) with videos related to

Pageof 19
Sort By:
Theranostics|April 17, 2023
Histone H3K27 methyltransferase EZH2 regulates apoptotic and inflammatory responses in sepsis-induced AKIBojun Li, Yuqi Xia, Shuqin Mei, et al.
Journal of Translational Medicine|February 2, 2025
Overview of preclinical and phase II clinical studies on Pegmolesatide's long-term erythropoiesis stimulating effect via EPOR-mediated signal transductionXiaoying Ma, Zhen Li, Lu Zhang, et al.
BMJ Open|February 9, 2020
RAPID-ADPKD (Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease): study protocol for a multinational, retrospective cohort studyHyunjin Ryu, Hayne C Park, Yun Kyu Oh, et al.
Kidney & Blood Pressure Research|November 22, 2016
Olmesartan Prevents Microalbuminuria in db/db Diabetic Mice Through Inhibition of Angiotensin II/p38/SIRT1-Induced Podocyte ApoptosisJunhui Gu, Ming Yang, Na Qi, et al.
Journal of Translational Medicine|July 1, 2021
Association between serum advanced oxidation protein products and mortality risk in maintenance hemodialysis patientsChun Zhou, Yuanyuan Zhang, Jianghua Chen, et al.
Frontiers in Pharmacology|October 25, 2023
Safety and effectiveness of HSK21542 for hemodialysis patients: a multiple ascending dose studyMingming Pan, Guihua Wang, Li Zhou, et al.
Nephrology (Carlton, Vic.)|June 29, 2012
Accumulation of circulating advanced oxidation protein products is an independent risk factor for ischaemic heart disease in maintenance haemodialysis patientsQiugen Zhou, Shengjie Wu, Jianping Jiang, et al.
Science Advances|June 12, 2019
Activation of P-TEFb by cAMP-PKA signaling in autosomal dominant polycystic kidney diseaseYongzhan Sun, Zhiheng Liu, Xinyi Cao, et al.
BMC Nephrology|February 3, 2019
Outcomes and practice patterns with hemodiafiltration in Shanghai: a longitudinal cohort studyWeiming Zhang, Changlin Mei, Nan Chen, et al.
Plos One|March 22, 2014
Clinical characteristics and disease predictors of a large Chinese cohort of patients with autosomal dominant polycystic kidney diseaseDongping Chen, Yiyi Ma, Xueqi Wang, et al.
Pageof 19

Showing results (161-170 of 181) with videos related to

Sort By:
Pageof 19
Theranostics|April 17, 2023
Histone H3K27 methyltransferase EZH2 regulates apoptotic and inflammatory responses in sepsis-induced AKIBojun Li, Yuqi Xia, Shuqin Mei, et al.
Journal of Translational Medicine|February 2, 2025
Overview of preclinical and phase II clinical studies on Pegmolesatide's long-term erythropoiesis stimulating effect via EPOR-mediated signal transductionXiaoying Ma, Zhen Li, Lu Zhang, et al.
BMJ Open|February 9, 2020
RAPID-ADPKD (Retrospective epidemiological study of Asia-Pacific patients with rapId Disease progression of Autosomal Dominant Polycystic Kidney Disease): study protocol for a multinational, retrospective cohort studyHyunjin Ryu, Hayne C Park, Yun Kyu Oh, et al.
Kidney & Blood Pressure Research|November 22, 2016
Olmesartan Prevents Microalbuminuria in db/db Diabetic Mice Through Inhibition of Angiotensin II/p38/SIRT1-Induced Podocyte ApoptosisJunhui Gu, Ming Yang, Na Qi, et al.
Journal of Translational Medicine|July 1, 2021
Association between serum advanced oxidation protein products and mortality risk in maintenance hemodialysis patientsChun Zhou, Yuanyuan Zhang, Jianghua Chen, et al.
Frontiers in Pharmacology|October 25, 2023
Safety and effectiveness of HSK21542 for hemodialysis patients: a multiple ascending dose studyMingming Pan, Guihua Wang, Li Zhou, et al.
Nephrology (Carlton, Vic.)|June 29, 2012
Accumulation of circulating advanced oxidation protein products is an independent risk factor for ischaemic heart disease in maintenance haemodialysis patientsQiugen Zhou, Shengjie Wu, Jianping Jiang, et al.
Science Advances|June 12, 2019
Activation of P-TEFb by cAMP-PKA signaling in autosomal dominant polycystic kidney diseaseYongzhan Sun, Zhiheng Liu, Xinyi Cao, et al.
BMC Nephrology|February 3, 2019
Outcomes and practice patterns with hemodiafiltration in Shanghai: a longitudinal cohort studyWeiming Zhang, Changlin Mei, Nan Chen, et al.
Plos One|March 22, 2014
Clinical characteristics and disease predictors of a large Chinese cohort of patients with autosomal dominant polycystic kidney diseaseDongping Chen, Yiyi Ma, Xueqi Wang, et al.
Pageof 19